228 related articles for article (PubMed ID: 12466246)
1. Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors.
Flau K; Redmer A; Liedtke S; Kathmann M; Schlicker E
Br J Pharmacol; 2002 Dec; 137(8):1355-61. PubMed ID: 12466246
[TBL] [Abstract][Full Text] [Related]
2. Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors.
Schlicker E; Werthwein S; Kathmann M; Bauer U
Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):418-22. PubMed ID: 9826063
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the ORL(1) receptor on adrenergic nerves in the rat anococcygeus muscle.
Ho M; Corbett AD; McKnight AT
Br J Pharmacol; 2000 Sep; 131(2):349-55. PubMed ID: 10991930
[TBL] [Abstract][Full Text] [Related]
4. Nociceptin/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata. A microdialysis study in the awake freely moving rat.
Marti M; Guerrini R; Beani L; Bianchi C; Morari M
Neuroscience; 2002; 112(1):153-60. PubMed ID: 12044480
[TBL] [Abstract][Full Text] [Related]
5. Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro.
Werthwein S; Bauer U; Nakazi M; Kathmann M; Schlicker E
Br J Pharmacol; 1999 May; 127(1):300-8. PubMed ID: 10369486
[TBL] [Abstract][Full Text] [Related]
6. The nociceptin/orphanin FQ receptor ligand acetyl-RYYRIK-amide exhibits antagonistic and agonistic properties.
Berger H; Bigoni R; Albrecht E; Richter RM; Krause E; Bienert M; Calo' G
Peptides; 2000 Jul; 21(7):1131-9. PubMed ID: 10998548
[TBL] [Abstract][Full Text] [Related]
7. [Nphe(1)]NC(1-13)NH(2) selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain.
Berger H; Calo' G; Albrecht E; Guerrini R; Bienert M
J Pharmacol Exp Ther; 2000 Aug; 294(2):428-33. PubMed ID: 10900215
[TBL] [Abstract][Full Text] [Related]
8. Direct and indirect inhibition by nociceptin/orphanin FQ on noradrenaline release from rodent cerebral cortex in vitro.
Siniscalchi A; Rodi D; Morari M; Marti M; Cavallini S; Marino S; Beani L; Bianchi C
Br J Pharmacol; 2002 Aug; 136(8):1178-84. PubMed ID: 12163351
[TBL] [Abstract][Full Text] [Related]
9. Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system.
Schlicker E; Morari M
Peptides; 2000 Jul; 21(7):1023-9. PubMed ID: 10998536
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol.
Gündüz O; Rizzi A; Baldisserotto A; Guerrini R; Spagnolo B; Gavioli EC; Kocsis L; Magyar A; Benyhe S; Borsodi A; Calò G
Eur J Pharmacol; 2006 Jun; 539(1-2):39-48. PubMed ID: 16682024
[TBL] [Abstract][Full Text] [Related]
11. In vitro characterization of Ac-RYYRWK-NH(2), Ac-RYYRIK-NH(2) and [Phe1Psi(CH(2)-NH)Gly2] nociceptin(1-13)NH(2) at rat native and recombinant ORL(1) receptors.
Mason SL; Ho M; Nicholson J; McKnight AT
Neuropeptides; 2001; 35(5-6):244-56. PubMed ID: 12030809
[TBL] [Abstract][Full Text] [Related]
12. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
Guerrini R; Caló G; Lambert DG; Carrá G; Arduin M; Barnes TA; McDonald J; Rizzi D; Trapella C; Marzola E; Rowbotham DJ; Regoli D; Salvadori S
J Med Chem; 2005 Mar; 48(5):1421-7. PubMed ID: 15743186
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex.
Mela F; Marti M; Ulazzi L; Vaccari E; Zucchini S; Trapella C; Salvadori S; Beani L; Bianchi C; Morari M
Eur J Neurosci; 2004 Mar; 19(5):1317-24. PubMed ID: 15016089
[TBL] [Abstract][Full Text] [Related]
14. [Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies.
Rizzi D; Rizzi A; Bigoni R; Camarda V; Marzola G; Guerrini R; De Risi C; Regoli D; Calo' G
J Pharmacol Exp Ther; 2002 Jan; 300(1):57-63. PubMed ID: 11752097
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
Kitayama M; Barnes TA; Carra G; McDonald J; Calo G; Guerrini R; Rowbotham DJ; Smith G; Lambert DG
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):528-37. PubMed ID: 14598020
[TBL] [Abstract][Full Text] [Related]
16. Acetyl-RYYRIK-NH(2) is a highly efficacious OP(4) receptor agonist in the cardiovascular system of anesthetized rats.
Malinowska B; Kozłowska H; Berger H; Schlicker E
Peptides; 2000 Dec; 21(12):1875-80. PubMed ID: 11150649
[TBL] [Abstract][Full Text] [Related]
17. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
[TBL] [Abstract][Full Text] [Related]
18. Selective and high affinity labeling of neuronal and recombinant nociceptin receptors with the hexapeptide radioprobe [(3)H]Ac-RYYRIK-ol.
Bojnik E; Farkas J; Magyar A; Tömböly C; Güçlü U; Gündüz O; Borsodi A; Corbani M; Benyhe S
Neurochem Int; 2009 Dec; 55(7):458-66. PubMed ID: 19414055
[TBL] [Abstract][Full Text] [Related]
19. Actions of orphanin FQ/nociceptin on rat ventral tegmental area neurons in vitro.
Zheng F; Grandy DK; Johnson SW
Br J Pharmacol; 2002 Aug; 136(7):1065-71. PubMed ID: 12145107
[TBL] [Abstract][Full Text] [Related]
20. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
Calo G; Rizzi A; Rizzi D; Bigoni R; Guerrini R; Marzola G; Marti M; McDonald J; Morari M; Lambert DG; Salvadori S; Regoli D
Br J Pharmacol; 2002 May; 136(2):303-11. PubMed ID: 12010780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
